Bhi Constipation Tablet
FDA Label NDC 62795-1005

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Medinatura Inc for the product Bhi Constipation (NDC 62795-1005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, inactive ingredients, purpose, uses, directions, warnings, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredients

Each tablet contains: *Dioscorea villosa 4X, Natrum muriaticum 200X, *Nux vomica 8X 100 mg each.

*Natural Ingredients

Inactive Ingredients

Lactose, Magnesium stearate

Purpose

Constipation Relief Tablets

Relieves:

• Constipation

• Bowel Irregularity

• Bloating

Uses

For the temporary relief of minor constipation, bowel irregularity, bloating

Directions

At first sign of symptoms:

Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

Standard dosage: Adults and children 4 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours. For children under 4, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow.

Warnings

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted.

Do not use if known sensitivity to BHI Constipation or any of its ingredients exists.

Keep Out Of Reach Of Children

Keep out of reach of children.

* Please review the disclaimer below.